Cargando…

Improving the large scale purification of the HIV microbicide, griffithsin

BACKGROUND: Griffithsin is a broad spectrum antiviral lectin that inhibits viral entry and maturation processes through binding clusters of oligomannose glycans on viral envelope glycoproteins. An efficient, scaleable manufacturing process for griffithsin active pharmaceutical ingredient (API) is es...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuqua, Joshua L, Wanga, Valentine, Palmer, Kenneth E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349730/
https://www.ncbi.nlm.nih.gov/pubmed/25887919
http://dx.doi.org/10.1186/s12896-015-0120-5
_version_ 1782360073147777024
author Fuqua, Joshua L
Wanga, Valentine
Palmer, Kenneth E
author_facet Fuqua, Joshua L
Wanga, Valentine
Palmer, Kenneth E
author_sort Fuqua, Joshua L
collection PubMed
description BACKGROUND: Griffithsin is a broad spectrum antiviral lectin that inhibits viral entry and maturation processes through binding clusters of oligomannose glycans on viral envelope glycoproteins. An efficient, scaleable manufacturing process for griffithsin active pharmaceutical ingredient (API) is essential for particularly cost-sensitive products such as griffithsin -based topical microbicides for HIV-1 prevention in resource poor settings. Our previously published purification method used ceramic filtration followed by two chromatography steps, resulting in a protein recovery of 30%. Our objective was to develop a scalable purification method for griffithsin expressed in Nicotiana benthamiana plants that would increase yield, reduce production costs, and simplify manufacturing techniques. Considering the future need to transfer griffithsin manufacturing technology to resource poor areas, we chose to focus modifying the purification process, paying particular attention to introducing simple, low-cost, and scalable procedures such as use of temperature, pH, ion concentration, and filtration to enhance product recovery. RESULTS: We achieved >99% pure griffithsin API by generating the initial green juice extract in pH 4 buffer, heating the extract to 55°C, incubating overnight with a bentonite MgCl(2) mixture, and final purification with Capto™ multimodal chromatography. Griffithsin extracted with this protocol maintains activity comparable to griffithsin purified by the previously published method and we are able to recover a substantially higher yield: 88 ± 5% of griffithsin from the initial extract. The method was scaled to produce gram quantities of griffithsin with high yields, low endotoxin levels, and low purification costs maintained. CONCLUSIONS: The methodology developed to purify griffithsin introduces and develops multiple tools for purification of recombinant proteins from plants at an industrial scale. These tools allow for robust cost-effective production and purification of griffithsin. The methodology can be readily scaled to the bench top or industry and process components can be used for purification of additional proteins based on biophysical characteristics.
format Online
Article
Text
id pubmed-4349730
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43497302015-03-05 Improving the large scale purification of the HIV microbicide, griffithsin Fuqua, Joshua L Wanga, Valentine Palmer, Kenneth E BMC Biotechnol Research Article BACKGROUND: Griffithsin is a broad spectrum antiviral lectin that inhibits viral entry and maturation processes through binding clusters of oligomannose glycans on viral envelope glycoproteins. An efficient, scaleable manufacturing process for griffithsin active pharmaceutical ingredient (API) is essential for particularly cost-sensitive products such as griffithsin -based topical microbicides for HIV-1 prevention in resource poor settings. Our previously published purification method used ceramic filtration followed by two chromatography steps, resulting in a protein recovery of 30%. Our objective was to develop a scalable purification method for griffithsin expressed in Nicotiana benthamiana plants that would increase yield, reduce production costs, and simplify manufacturing techniques. Considering the future need to transfer griffithsin manufacturing technology to resource poor areas, we chose to focus modifying the purification process, paying particular attention to introducing simple, low-cost, and scalable procedures such as use of temperature, pH, ion concentration, and filtration to enhance product recovery. RESULTS: We achieved >99% pure griffithsin API by generating the initial green juice extract in pH 4 buffer, heating the extract to 55°C, incubating overnight with a bentonite MgCl(2) mixture, and final purification with Capto™ multimodal chromatography. Griffithsin extracted with this protocol maintains activity comparable to griffithsin purified by the previously published method and we are able to recover a substantially higher yield: 88 ± 5% of griffithsin from the initial extract. The method was scaled to produce gram quantities of griffithsin with high yields, low endotoxin levels, and low purification costs maintained. CONCLUSIONS: The methodology developed to purify griffithsin introduces and develops multiple tools for purification of recombinant proteins from plants at an industrial scale. These tools allow for robust cost-effective production and purification of griffithsin. The methodology can be readily scaled to the bench top or industry and process components can be used for purification of additional proteins based on biophysical characteristics. BioMed Central 2015-02-22 /pmc/articles/PMC4349730/ /pubmed/25887919 http://dx.doi.org/10.1186/s12896-015-0120-5 Text en © Fuqua et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Fuqua, Joshua L
Wanga, Valentine
Palmer, Kenneth E
Improving the large scale purification of the HIV microbicide, griffithsin
title Improving the large scale purification of the HIV microbicide, griffithsin
title_full Improving the large scale purification of the HIV microbicide, griffithsin
title_fullStr Improving the large scale purification of the HIV microbicide, griffithsin
title_full_unstemmed Improving the large scale purification of the HIV microbicide, griffithsin
title_short Improving the large scale purification of the HIV microbicide, griffithsin
title_sort improving the large scale purification of the hiv microbicide, griffithsin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349730/
https://www.ncbi.nlm.nih.gov/pubmed/25887919
http://dx.doi.org/10.1186/s12896-015-0120-5
work_keys_str_mv AT fuquajoshual improvingthelargescalepurificationofthehivmicrobicidegriffithsin
AT wangavalentine improvingthelargescalepurificationofthehivmicrobicidegriffithsin
AT palmerkennethe improvingthelargescalepurificationofthehivmicrobicidegriffithsin